Articles
Maximising Drug Discovery Research
Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists should focus on the biological relevance of their candidate...
Clinical Trials
Plexxikon Initiates Phase 1 Clinical Trial for Oral Rheumatoid Arthritis Agent PLX5622
Plexxikon Inc. announced that dosing began in the first of two Phase 1 clinical trials with PLX5622, a novel, oral and highly selective Fms...
Clinical Trials
Sanofi-aventis Reports Top-line Results from Phase III Study with BSI-201 in Metastatic Triple-Negative Breast Cancer
Sanofi-aventis and its subsidiary, BiPar Sciences, announced that a randomized Phase III trial evaluating BSI-201 (iniparib*) in patients with metastatic triple-negative breast cancer (mTNBC)...
News
Tobotec Signs Multiple Agreements With Generic Manufacturers To Provide New HIV Treatment
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company)...
Techno Trends
New Technology Platform For Testing Drugs
Birkbeck and Southampton researchers pioneer new technology for pharmaceutical drug developmen for testing drugs will simplify the process and drive new research for the...
Industry Reports
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies, or cc) to USD 50.6 billion. Solid sales growth...
News
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies, or cc) to USD 50.6 billion. Solid sales growth...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read